SQI’sLife Science Researchprogram provides seamless application of dual-layer multiplexing™ for pharmaceutical companies conducting clinical research on their drug development programs. Beyondthe ability to report multiple proteins, plus multiple immunoglobulin isotypes and subclasses simultaneously, the system allows you to test all those targets in one well and provides timely expert assay development andcustomized solutions.

Immunogenicity – Biomarkers (cytokines) – Custom assay development – Xplex Personal Assay Development

Note: Per our last discussion we said to have a section for Surgeons, Physicians and Patients under this section once tests are FDA approved